Zenith Healthcare Ltd

ZEHC.IN

$0.05

Closing

▲0.89%

1D

▼-16.94%

YTD

Market cap

$2.90M

52 week high

$0.08

52 week low

$0.04

Volume

42,831

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$2.90M

Analysts' Rating

-

Price Target (Mean)

Unable to collect data for some field(s).

Total Analysts

0

P/E

94.37

Operating Margin

2.18%

Beta

1.57

Revenue Growth (Annual)

-45.51%

52 week high

$0.08

52 week low

$0.04

Div. Yield

%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Zenith Healthcare Limited is primarily engaged in the manufacturing of pharmaceutical formulations in the forms of tablets, capsules, oral liquids and injectables. The Company offers its products across various therapeutic segments, including antibiotics and anti-infective, gastrointestinal tract, analgesic/anti-inflammatory, cardiovascular system, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system and skin. Its products across antibiotics and anti-infective categories include Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension and Azithromycin Oral Suspension. Its product across the gastrointestinal category includes Ranitidine Hydrochloride Tablets. Its product across the cardiovascular system includes Lisinopril Tablets. Its products across the analgesic category include Paracetamol and Aceclofenac Tablets. It offers contract manufacturing of all dosage forms.